CAS: 777859-74-2

Methyl 2-bromo-6-(bromomethyl)benzoate is a pharmacological agent that belongs to the group of dopamine D2-like receptor ligands. It has been shown to bind to the dopamine D2-like receptor in rat brain tissue, and has affinity for this receptor. Methyl 2-bromo-6-(bromomethyl)benzoate may induce behavioral effects by interacting with the dopamine system in the central nervous system. This compound binds to dopamine receptors, especially those with affinity for D2-like subtypes. The binding of this compound induces conformational changes in the receptor, which leads to changes in downstream signal transduction and ultimately influences behavior.